✦ LIBER ✦

Efficacy and safety of telaprevir (TVR) triple therapy in a ‘real-life’ cohort of 102 patients with HCV genotype 1: interim analysis after 24 weeks of treatment

✍ Scribed by Werner, C. R.; Franz, C.; Egetemeyr, D. P.; Janke-Maier, P.; Malek, N. P.; Lauer, U. M.; Berg, C. P.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

805 WEEK 4 AND 12 EFFICACY OF TELAPREVIR

✍ Christensen, S.; Mauss, S.; Eisenbach, C.; Jung, M.-C.; Roessle, M.; Emke, F.; P 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 59 KB

799 EFFICACY AND SAFETY OF TRIPLE-THERAP

✍ Calleja, J.L.; Pascasio, J.M.; Ruiz-Antoran, B.; Larrubia, J.R.; Gea, F.; de la 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 129 KB

Safety and efficacy of protease inhibito

✍ Wehmeyer, Malte H; Eißing, Friederike; Jordan, Sabine; Röder, Claudia; Hennigs, 📂 Article 📅 2014 🏛 BioMed Central 🌐 English ⚖ 342 KB

Sa1051 Boceprevir Based Triple Therapy i

✍ Moog, Gero; Mauss, Stefan; Hueppe, Dietrich; Spengler, Ulrich; Schott, Eckart; E 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 646 KB